Latest Breaking News On - ஒன்று ஆய்வகங்கள் - Page 7 : comparemela.com

Core One Labs Inc.: Core One Labs Initiates First Strain Production for Biosynthetic Psilocybin VANCOUVER, BC / ACCESSWIRE / February 26, 2021 / Core One Labs Inc. (CSE:COOL), (OTC PINK:CLABF), (Frankfurt:LD62, WKN: A2P8K3) (the Company or Core One ) a biotechnology research and development life sciences enterprise focused on advancing psychedelic medicines to market, is pleased to announce readiness to begin initial biosynthetic psilocybin production trials. The Company s wholly owned subsidiary, Vocan Biotechnologies Inc. of Victoria, British Columbia, has successfully completed the development of its psilocybin detection and quantification methodology. This significant achievement allows the Company to commence production trials with its first psilocybin producer strain.

United kingdomBritish columbiaJoel shackerCompany or core oneCore one labs incVocan biotechnologies incHealth canadaCanadian securities exchangeCore one labsVocan biotechnologiesCore oneOne labsDisclaimer statementControlled drugsSubstances actஒன்றுபட்டது கிஂக்டம்